Diagnosis and treatment of hypertensive disorders during pregnancy

Acta Clinica Belgica

Volumn 65, Issue 4, 2010, Pages 229-236

  Fabry, Isabelle G ^a   Richart, T ^b,c   Cheng, X ^b,c   Van Bortel, L M ^a   Staessen, J A ^b,c  

^a GHENT UNIVERSITY   (Belgium)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Haemodynamics; Hypertension; Pregnancy

Indexed keywords

ACEBUTOLOL; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETAXOLOL; BISOPROLOL; BUMETANIDE; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DIHYDROPYRIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FELODIPINE; FUROSEMIDE; GUANFACINE; HYDRALAZINE; HYDROCORTISONE; LABETALOL; METHYLDOPA; METOPROLOL; MOXONIDINE; NEBIVOLOL; NIFEDIPINE; PINDOLOL; PRAZOSIN; PROPRANOLOL; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VERAPAMIL;

ANGINA PECTORIS; ANOREXIA; ARTERIAL OXYGEN TENSION; BLOOD CLOTTING DISORDER; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BREAST FEEDING; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DIZZINESS; DRUG CONTRAINDICATION; DRUG SAFETY; EARLY DIAGNOSIS; ECLAMPSIA; EDEMA; ENDOCRINE FUNCTION; ENDOTHELIAL DYSFUNCTION; EPIGASTRIC PAIN; ERYTHROCYTE; FACE DYSMORPHIA; FATIGUE; FETUS DEATH; FETUS MORTALITY; GLAUCOMA; HEART ARRHYTHMIA; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE ARRHYTHMIA; HELLP SYNDROME; HEMODYNAMIC PARAMETERS; HEMOLYTIC UREMIC SYNDROME; HORMONE RELEASE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INCIDENCE; INFLAMMATION; INFORMATION RETRIEVAL; INTRAUTERINE GROWTH RETARDATION; JAUNDICE; KIDNEY FAILURE; LIVER BIOPSY; LIVER DYSFUNCTION; LIVER FATTY DEGENERATION; LUNG HYPOPLASIA; MAINTENANCE THERAPY; MALAISE; MATERNAL CARE; MATERNAL HYPERTENSION; MATERNAL MORBIDITY; MATERNAL MORTALITY; MENTAL DISEASE; MICROANGIOGRAPHY; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OLIGOHYDRAMNIOS; ORTHOSTATIC HYPOTENSION; OSMOLALITY; OXIDATIVE STRESS; PLASMA VOLUME; PRACTICE GUIDELINE; PREECLAMPSIA; PROTEINURIA; RAYNAUD PHENOMENON; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SAFETY; SMOKING; SOLUTIO PLACENTAE; SYMPATHOLYSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULAR RESISTANCE; TERATOGENICITY; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT INDICATION; UTERUS BLOOD FLOW; VASOSPASTIC ANGINA; VOMITING;

EID: 77957000553     PISSN: 00015512     EISSN: None     Source Type: Journal    
DOI: 10.1179/acb.2010.050     Document Type: Review

References (54)

1. Duvekot JJ, Peeters LL. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv 1994; 49(12 Suppl): S1-14.
2. Voss A, Malberg H, Schumann A, Wessel N, Walther T, Stepan H, Faber R. Baroreflex sensitivity, heart rate, and blood pressure variability in normal pregnancy. Am J Hypertens 2000;1 3(11): 1218-25.
3. Finn WL, Tunny TJ, Klemm SA, Jones IS, De VK, Gordon RD. Sodium and volume dysregulation after apparently normal pregnancy is suggested by abnormal levels of atrial natriuretic peptide, renin and aldosterone. Clin Exp Pharmacol Physiol 1991; 18(5): 269-73.
4. Schrier RW, Briner VA. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol 1991; 77(4): 632-9.
5. Duvekot JJ, Cheriex EC, Pieters FA, Menheere PP, Peeters LH. Early pregnancy changes in hemodynamics and volume homeostasis are consecutive adjustments triggered by a primary fall in systemic vascular tone. Am J Obstet Gynecol 1993; 169(6): 1382-92.
6. Weiner CP, Thompson LP. Nitric oxide and pregnancy. Semin Perinatol 1997; 21(5): 367-80.
7. Baylis C. Glomerular filtration and volume regulation in gravid animal models. Baillieres Clin Obstet Gynaecol 1994; 8(2): 235-64.
8. Khraibi AA. Renal interstitial hydrostatic pressure and sodium excretion in hypertension and pregnancy. J Hypertens Suppl 2002; 20(3): S21-S27.
9. Khraibi AA, Yu T, Tang D. Role of nitric oxide in the natriuretic and diuretic responses in pregnant rats. Am J Physiol Renal Physiol 2003; 285(5): F938-F944.
10. Carbillon L, Uzan M, Uzan S. Pregnancy, vascular tone, and maternal hemodynamics: a crucial adaptation. Obstet Gynecol Surv 2000; 55(9): 574-81.
11. Chapman AB, Abraham WT, Zamudio S, Coffin C, Merouani A, Young D, Johnson A, Osorio F, Goldberg C, Moore LG, Dahms T, Schrier RW. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998; 54(6): 2056-63.
12. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol 2000; 24(1): 11-4.
13. Blake MJ, Martin A, Manktelow BN, Armstrong C, Halligan AW, Panerai RB, Potter JF. Changes in baroreceptor sensitivity for heart rate during normotensive pregnancy and the Puerperium. Clin Sci (Lond) 2000; 98(3): 259-68.
14. Jensen E, Wood C, Keller-Wood M.The normal increase in adrenal secretion during pregnancy contributes to maternal volume expansion and fetal homeostasis. J Soc Gynecol Investig 2002; 9(6): 362-71.
15. Duvekot JJ, Peeters LL. Renal hemodynamics and volume homeostasis in pregnancy. Obstet Gynecol Surv 1994; 49(12): 830-9.
16. van der Post JA, van Buul BJ, Hart AA, van Heerikhuize JJ, Pesman G, Legros JJ, Steegers EA, Swaab DF, Boer K.Vasopressin and oxytocin levels during normal pregnancy: effects of chronic dietary sodium restriction. J Endocrinol 1997; 152(3): 345-54.
17. Eguchi K, Oguni N, Sawai T, Yonezawa M. Comparison of plasma concentrations of arginine vasopressin (AVP) and atrial natriuretic peptide (ANP) in normal and preeclamptic pregnancies. J Perinat Med 1996; 24(5): 437-43.
18. Ganzevoort W, Rep A, Bonsel GJ, de Vries JI, Wolf H. Plasma volume and blood pressure regulation in hypertensive pregnancy. J Hypertens 2004; 22(7): 1235-42.
19. Garovic VD, Hayman SR. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nat Clin Pract Nephrol 2007; 3(11): 613-22.
20. Yoder SR, Thornburg LL, Bisognano JD. Hypertension in pregnancy and women of childbearing age. Am J Med 2009; 122(10): 890-5.
21. Podymow T, August P. Update on the use of antihypertensive drugs in pregnancy. Hypertension 2008; 51(4): 960-9.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr., Jones DW, Materson BJ, Oparil S, Wright JT, Jr., Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289(19): 2560-72.
23. Mancia G, De BG, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH- ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25(9): 1751-62.
24. Artal R, Lockwood CJ, Brown HL. Weight gain recommendations in pregnancy and the obesity epidemic. Obstet Gynecol 2010; 115(1): 152-5.
25. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, Paul RH. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995; 172(2 Pt 1): 642-8.
26. Engel SM, Janevic TM, Stein CR, Savitz DA. Maternal smoking, preeclampsia, and infant health outcomes in New York City, 1995-2003. Am J Epidemiol 2009; 169(1): 33-40.
27. Sibai BM. Caring for women with hypertension in pregnancy. JAMA 2007; 298(13): 1566-8.
28. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367(9516): 1066-74.
29. Jonsdottir LS, Arngrimsson R, Geirsson RT, Sigvaldason H, Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand 1995; 74(10): 772-6.
30. Arnadottir GA, Geirsson RT, Arngrimsson R, Jonsdottir LS, Olafsson O. Cardiovascular death in women who had hypertension in pregnancy: a case-control study. BJOG 2005; 112(3): 286-92.
31. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008; 156(5): 918-30.
32. Leeman M. [Arterial hypertension in pregnancy]. Rev Med Brux 2008; 29(4): 340-5.
33. Buemi M, Bolignano D, Barilla A, Nostra L, Crasci E, Campo S, Coppolino G, D'Anna R. Preeclampsia and cardiovascular risk: general characteristics, counseling and follow-up. J Nephrol 2008; 21(5): 663-72.
34. Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late pre-eclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52(5): 873-80.
35. Smith GN, Walker MC, Liu A, Wen SW, Swansburg M, Ramshaw H, White RR, Roddy M, Hladunewich M. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200(1): 58.
36. Poranen AK, Ekblad U, Uotila P, Ahotupa M. Lipid peroxidation and antioxidants in normal and pre-eclamptic pregnancies. Placenta 1996; 17(7): 401-5.
37. Many A, Hubel CA, Fisher SJ, Roberts JM, Zhou Y. Invasive cytotrophoblasts manifest evidence of oxidative stress in preeclampsia. Am J Pathol 2000; 156(1): 321-31.
38. Freeman DJ, McManus F, Brown EA, Cherry L, Norrie J, Ramsay JE, Clark P, Walker ID, Sattar N, Greer IA. Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension 2004; 44(5): 708-14.
39. Austgulen R, Lien E, Vince G, Redman CW. Increased maternal plasma levels of soluble adhesion molecules (ICAM-1, VCAM-1, E-selectin) in preeclampsia. Eur J Obstet Gynecol Reprod Biol 1997; 71(1): 53-8.
40. Greer IA, Dawes J, Johnston TA, Calder AA. Neutrophil activation is confined to the maternal circulation in pregnancy-induced hypertension. Obstet Gynecol 1991; 78(1): 28-32.
41. Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982; 142(2): 159-67.
42. Egerman RS, Sibai BM. HELLP syndrome. Clin Obstet Gynecol 1999; 42(2): 381-9.
43. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet 2010; 375(9714): 594-605.
44. Sibai BM. Imitators of severe pre-eclampsia. Semin Perinatol 2009 June;33(3):196-205.
45. Tincani A, Bompane D, Danieli E, Doria A. Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 2006; 15(3): 156-60.
46. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346(10): 752-63.
47. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001; (2): CD002252.
48. Gebruik van antihypertensive tijdens de zwangerschap. www.bcfi.be/ folia/2005/F32N01B.cfm. 2005. Ref Type: Internet Communication
49. Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG 2000 June;107(6):792-4.
50. Rubin PC, Butters L, Low RA, Reid JL. Atenolol in the treatment of essential hypertension during pregnancy. Br J Clin Pharmacol 1982; 14(2): 279-81.
51. Cooper WO, Hernandez-Diaz S, Arbogast PG, Dudley JA, Dyer S, Gideon PS, Hall K, Ray WA. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354(23): 2443-51.
52. Clapp JF, III, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol 1997; 80(11): 1469-73.
53. website of the U.S. Food and Drug Administration. www.fda.com. 2010. Ref Type: Internet Communication
54. Drugs in Pregnancy and Breastfeeding. www.safefetus.com/. 2010. Ref Type: Internet Communication